Reduce costs associated with pre-dilution and improve data quality! Implemented in routine tasks within a few months after introduction.
MorphoSys, a company based in Germany specializing in the research and development of antibodies, has extensive experience in designing novel assays aimed at screening and characterizing therapeutic antibodies. The company's technology development department has secured the processing capacity necessary for the development of its products by utilizing various automation solutions. However, the dilution of antibodies for screening has always been done manually, creating a bottleneck in the workflow. Therefore, we proposed the 'D300e Digital Dispenser,' which can use aqueous solutions. The ability to reduce costs associated with pre-dilution and eliminate waste was the deciding factor for the introduction of this product. [Case Study] - Client: MorphoSys - Challenge: Automated production of dilution antibodies for screening - Product Introduced: "D300e Digital Dispenser" *For more details, please refer to the PDF document or feel free to contact us.*
Inquire About This Product
basic information
【Benefits of Introduction】 ■Significantly reduce the amount of materials needed for each experiment ■Minimize the cost of consumables ■Increase accuracy in micro-dispensing, improving data quality ■Expand the scope of experiments in many research studies *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（4）
Download All Catalogs![[D300e Introduction Case] MorphoSys Corporation](https://image.mono.ipros.com/public/catalog/image_generated/01/89d/404498/404498_IPROS8539613384376230818_1.jpg?w=120&h=170)
![[D300e Case Study] zPREDICTA develops 3D technology that enables the reconstruction organ (r-Organ) platform.](https://image.mono.ipros.com/public/catalog/image/01/2ca/504335/IPROS92808377967704111536.jpeg?w=120&h=170)
Company information
Tecan is a company that was established in Switzerland in 1980, specializing in the manufacturing and development of life science research support equipment. With the support of many customers, we were able to celebrate our 30th anniversary in Japan in 2022. Tecan Japan operates two businesses. One is the life sciences business, which delivers Tecan-branded products such as automated pipetting systems and microplate readers to end-users. The other is the partnering business, which provides components and equipment as OEM products for partner companies. Our customers span a wide range of fields, including disease research, drug discovery, biotechnology, clinical testing (such as cancer diagnosis, infectious disease diagnosis, and testing centers), scientific analysis, and robotic surgery. Our mission is to improve people's lives and health. Tecan Japan aims to contribute to global health care innovation from the life sciences industry to clinics by supporting our customers' daily activities.
